C1orf35 anticorps (AA 27-154)

N° du produit ABIN7873078

Cet anticorps anti-C1orf35 Polyclonal Lapin (ABIN7873078) détecte spécifiquement C1orf35 dans WB, ELISA et FACS. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour C1orf35 anticorps (AA 27-154) (ABIN7873078)

Antigène: C1orf35 (Chromosome 1 Open Reading Frame 35 (C1orf35))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C1orf35 est non-conjugé

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Détail du produit anti-C1orf35 anticorps

Épitope: AA 27-154

Fonction: MMTAG2 Antibody / Mammary tumor antigen 2

Purification: Immunogen affinity purified

Immunogène: E.coli-derived human C1orf35/MMTAG2 recombinant protein (Position: R27-E154) was used as the immunogen for the MMTAG2 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the MMTAG2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the MMTAG2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur C1orf35

Antigène: C1orf35 (Chromosome 1 Open Reading Frame 35 (C1orf35))

Autre désignation: MMTAG2

Sujet: MMTAG2 antibody detects Mammary tumor antigen 2, encoded by the MMTAG2 gene. Mammary tumor antigen 2 is a protein identified in the context of murine mammary tumors and is associated with tumorigenesis, immune recognition, and viral oncogenesis. MMTAG2 antibody provides researchers with a specialized reagent for studying mammary tumor biology, retroviral gene products, and tumor-associated antigens.

Mammary tumor antigen 2 was originally characterized as a retrovirus-derived protein expressed in murine mammary tumor virus (MMTV)-associated cancers. Research using MMTAG2 antibody has shown that it is expressed in mammary gland tumors and may play roles in viral replication or oncogenic transformation. Its association with tumor cell surfaces makes it a useful marker for identifying tumor cells in certain model systems.

Studies with MMTAG2 antibody have revealed that immune responses can be directed against mammary tumor antigens, including MMTAG2, suggesting roles in host immune surveillance and tumor immunology. Expression of MMTAG2 has been correlated with tumor progression and malignancy in murine models, making it a useful biomarker in cancer research involving retrovirus-driven systems.

While less studied in human biology, mammary tumor antigen 2 and related proteins provide important insight into viral oncology, retroviral integration, and antigen-driven immune responses. Research using MMTAG2 antibody continues to explore its potential roles as a diagnostic tool and as part of mechanistic studies into MMTV-related tumorigenesis.

MMTAG2 antibody is widely applied in immunohistochemistry, immunofluorescence, and western blotting in murine mammary tumor samples. These applications highlight its value in preclinical research focused on virus-associated cancers. By identifying mammary tumor antigen 2, researchers can better understand retroviral contributions to tumor biology.

By providing validated MMTAG2 antibody reagents, NSJ Bioreagents supports studies into mammary tumor biology, viral oncogenesis, and cancer immunology. Detection of Mammary tumor antigen 2 provides researchers with insight into how viral proteins contribute to tumor development and immune recognition.

UniProt: Q9BU76